Which has better earnings & valuation, OPRX or PAYS?

Paysign has lower revenue, but higher earnings than OptimizeRx. OptimizeRx is trading at a lower price-to-earnings ratio than Paysign, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OptimizeRx $109.43M 1.13 $5.13M $0.35 18.77 Paysign $82.03M 6.27 $7.55M $0.17 54.14

Is OPRX or PAYS more profitable?

Paysign has a net margin of 11.38% compared to OptimizeRx's net margin of 6.37%. Paysign's return on equity of 21.74% beat OptimizeRx's return on equity. Company Net Margins Return on Equity Return on Assets OptimizeRx 6.37% 10.86% 7.93% Paysign 11.38% 21.74% 4.19%

Does the media prefer OPRX or PAYS?

In the previous week, OptimizeRx had 1 more articles in the media than Paysign. MarketBeat recorded 5 mentions for OptimizeRx and 4 mentions for Paysign. OptimizeRx's average media sentiment score of 0.58 beat Paysign's score of 0.47 indicating that OptimizeRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OptimizeRx 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Paysign 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, OPRX or IBEX?

IBEX has higher revenue and earnings than OptimizeRx. IBEX is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OptimizeRx $109.43M 1.13 $5.13M $0.35 18.77 IBEX $558.27M 0.81 $36.86M $3.20 10.61

Is OPRX or IBEX more profitable?

IBEX has a net margin of 7.53% compared to OptimizeRx's net margin of 6.37%. IBEX's return on equity of 31.50% beat OptimizeRx's return on equity. Company Net Margins Return on Equity Return on Assets OptimizeRx 6.37% 10.86% 7.93% IBEX 7.53% 31.50% 16.25%

Does the media prefer OPRX or IBEX?

In the previous week, OptimizeRx had 3 more articles in the media than IBEX. MarketBeat recorded 5 mentions for OptimizeRx and 2 mentions for IBEX. IBEX's average media sentiment score of 0.94 beat OptimizeRx's score of 0.58 indicating that IBEX is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OptimizeRx 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IBEX 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend OPRX or GRVY?

OptimizeRx presently has a consensus price target of $13.43, indicating a potential upside of 104.39%. Given OptimizeRx's stronger consensus rating and higher probable upside, equities analysts clearly believe OptimizeRx is more favorable than GRAVITY. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OptimizeRx 1 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.56 GRAVITY 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable valuation & earnings, OPRX or GRVY?

GRAVITY has higher revenue and earnings than OptimizeRx. GRAVITY is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OptimizeRx $109.43M 1.13 $5.13M $0.35 18.77 GRAVITY $388.04M 1.12 $47.22M $7.30 8.58

Is OPRX or GRVY more profitable?

GRAVITY has a net margin of 12.63% compared to OptimizeRx's net margin of 6.37%. GRAVITY's return on equity of 11.44% beat OptimizeRx's return on equity. Company Net Margins Return on Equity Return on Assets OptimizeRx 6.37% 10.86% 7.93% GRAVITY 12.63% 11.44% 9.68%

Does the media prefer OPRX or GRVY?

In the previous week, OptimizeRx had 3 more articles in the media than GRAVITY. MarketBeat recorded 5 mentions for OptimizeRx and 2 mentions for GRAVITY. GRAVITY's average media sentiment score of 1.24 beat OptimizeRx's score of 0.58 indicating that GRAVITY is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OptimizeRx 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GRAVITY 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, RMNI or OPRX?

Rimini Street has higher revenue and earnings than OptimizeRx. Rimini Street is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Rimini Street $421.54M 1.04 $37.10M $0.37 12.74 OptimizeRx $109.43M 1.13 $5.13M $0.35 18.77

Does the media favor RMNI or OPRX?

In the previous week, OptimizeRx had 2 more articles in the media than Rimini Street. MarketBeat recorded 5 mentions for OptimizeRx and 3 mentions for Rimini Street. Rimini Street's average media sentiment score of 1.04 beat OptimizeRx's score of 0.58 indicating that Rimini Street is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rimini Street 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OptimizeRx 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate IMXI or OPRX?

OptimizeRx has a consensus target price of $13.43, suggesting a potential upside of 104.39%. Given OptimizeRx's stronger consensus rating and higher possible upside, analysts plainly believe OptimizeRx is more favorable than International Money Express. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score International Money Express 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 OptimizeRx 1 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.56

Does the media favor IMXI or OPRX?

In the previous week, OptimizeRx had 3 more articles in the media than International Money Express. MarketBeat recorded 5 mentions for OptimizeRx and 2 mentions for International Money Express. International Money Express' average media sentiment score of 0.94 beat OptimizeRx's score of 0.58 indicating that International Money Express is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment International Money Express 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OptimizeRx 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

OptimizeRx (OPRX) Competitors

$6.57 +0.02 (+0.31%)

As of 10:58 AM Eastern

Compare

OPRX vs. PAYS, IBEX, GRVY, RMNI, and IMXI

Should you buy OptimizeRx stock or one of its competitors? MarketBeat compares OptimizeRx with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with OptimizeRx include Paysign (PAYS), IBEX (IBEX), GRAVITY (GRVY), Rimini Street (RMNI), and International Money Express (IMXI). These companies are all part of the "business services" industry.

How does OptimizeRx compare to Paysign?

OptimizeRx (NASDAQ:OPRX) and Paysign (NASDAQ:PAYS) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation.

Paysign has a net margin of 11.38% compared to OptimizeRx's net margin of 6.37%. Paysign's return on equity of 21.74% beat OptimizeRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OptimizeRx	6.37%	10.86%	7.93%
Paysign	11.38%	21.74%	4.19%

Paysign has lower revenue, but higher earnings than OptimizeRx. OptimizeRx is trading at a lower price-to-earnings ratio than Paysign, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$109.43M	1.13	$5.13M	$0.35	18.77
Paysign	$82.03M	6.27	$7.55M	$0.17	54.14

76.5% of OptimizeRx shares are held by institutional investors. Comparatively, 25.9% of Paysign shares are held by institutional investors. 7.5% of OptimizeRx shares are held by company insiders. Comparatively, 24.5% of Paysign shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

OptimizeRx has a beta of 1.08, indicating that its share price is 8% more volatile than the broader market. Comparatively, Paysign has a beta of 0.72, indicating that its share price is 28% less volatile than the broader market.

OptimizeRx presently has a consensus price target of $13.43, indicating a potential upside of 104.39%. Paysign has a consensus price target of $10.00, indicating a potential upside of 8.66%. Given OptimizeRx's higher probable upside, equities analysts clearly believe OptimizeRx is more favorable than Paysign.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
Paysign	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, OptimizeRx had 1 more articles in the media than Paysign. MarketBeat recorded 5 mentions for OptimizeRx and 4 mentions for Paysign. OptimizeRx's average media sentiment score of 0.58 beat Paysign's score of 0.47 indicating that OptimizeRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OptimizeRx	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Paysign	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

OptimizeRx beats Paysign on 9 of the 16 factors compared between the two stocks.

How does OptimizeRx compare to IBEX?

OptimizeRx (NASDAQ:OPRX) and IBEX (NASDAQ:IBEX) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

IBEX has a net margin of 7.53% compared to OptimizeRx's net margin of 6.37%. IBEX's return on equity of 31.50% beat OptimizeRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OptimizeRx	6.37%	10.86%	7.93%
IBEX	7.53%	31.50%	16.25%

76.5% of OptimizeRx shares are owned by institutional investors. Comparatively, 81.2% of IBEX shares are owned by institutional investors. 7.5% of OptimizeRx shares are owned by company insiders. Comparatively, 3.4% of IBEX shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

OptimizeRx has a beta of 1.08, meaning that its share price is 8% more volatile than the broader market. Comparatively, IBEX has a beta of 0.71, meaning that its share price is 29% less volatile than the broader market.

OptimizeRx presently has a consensus target price of $13.43, indicating a potential upside of 104.39%. IBEX has a consensus target price of $40.00, indicating a potential upside of 17.87%. Given OptimizeRx's stronger consensus rating and higher possible upside, equities research analysts clearly believe OptimizeRx is more favorable than IBEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
IBEX	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

IBEX has higher revenue and earnings than OptimizeRx. IBEX is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$109.43M	1.13	$5.13M	$0.35	18.77
IBEX	$558.27M	0.81	$36.86M	$3.20	10.61

In the previous week, OptimizeRx had 3 more articles in the media than IBEX. MarketBeat recorded 5 mentions for OptimizeRx and 2 mentions for IBEX. IBEX's average media sentiment score of 0.94 beat OptimizeRx's score of 0.58 indicating that IBEX is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OptimizeRx	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IBEX	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

OptimizeRx and IBEX tied by winning 8 of the 16 factors compared between the two stocks.

How does OptimizeRx compare to GRAVITY?

OptimizeRx (NASDAQ:OPRX) and GRAVITY (NASDAQ:GRVY) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

GRAVITY has a net margin of 12.63% compared to OptimizeRx's net margin of 6.37%. GRAVITY's return on equity of 11.44% beat OptimizeRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OptimizeRx	6.37%	10.86%	7.93%
GRAVITY	12.63%	11.44%	9.68%

OptimizeRx has a beta of 1.08, meaning that its share price is 8% more volatile than the broader market. Comparatively, GRAVITY has a beta of 1.01, meaning that its share price is 1% more volatile than the broader market.

76.5% of OptimizeRx shares are held by institutional investors. Comparatively, 9.9% of GRAVITY shares are held by institutional investors. 7.5% of OptimizeRx shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

GRAVITY has higher revenue and earnings than OptimizeRx. GRAVITY is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$109.43M	1.13	$5.13M	$0.35	18.77
GRAVITY	$388.04M	1.12	$47.22M	$7.30	8.58

OptimizeRx presently has a consensus price target of $13.43, indicating a potential upside of 104.39%. Given OptimizeRx's stronger consensus rating and higher probable upside, equities analysts clearly believe OptimizeRx is more favorable than GRAVITY.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
GRAVITY	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, OptimizeRx had 3 more articles in the media than GRAVITY. MarketBeat recorded 5 mentions for OptimizeRx and 2 mentions for GRAVITY. GRAVITY's average media sentiment score of 1.24 beat OptimizeRx's score of 0.58 indicating that GRAVITY is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OptimizeRx	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
GRAVITY	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

OptimizeRx beats GRAVITY on 9 of the 16 factors compared between the two stocks.

How does OptimizeRx compare to Rimini Street?

Rimini Street (NASDAQ:RMNI) and OptimizeRx (NASDAQ:OPRX) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

73.8% of Rimini Street shares are held by institutional investors. Comparatively, 76.5% of OptimizeRx shares are held by institutional investors. 42.0% of Rimini Street shares are held by insiders. Comparatively, 7.5% of OptimizeRx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Rimini Street has a beta of 1.28, suggesting that its share price is 28% more volatile than the broader market. Comparatively, OptimizeRx has a beta of 1.08, suggesting that its share price is 8% more volatile than the broader market.

In the previous week, OptimizeRx had 2 more articles in the media than Rimini Street. MarketBeat recorded 5 mentions for OptimizeRx and 3 mentions for Rimini Street. Rimini Street's average media sentiment score of 1.04 beat OptimizeRx's score of 0.58 indicating that Rimini Street is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rimini Street	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OptimizeRx	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Rimini Street currently has a consensus price target of $4.50, suggesting a potential downside of 4.56%. OptimizeRx has a consensus price target of $13.43, suggesting a potential upside of 104.39%. Given OptimizeRx's stronger consensus rating and higher probable upside, analysts plainly believe OptimizeRx is more favorable than Rimini Street.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rimini Street	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

Rimini Street has a net margin of 8.30% compared to OptimizeRx's net margin of 6.37%. OptimizeRx's return on equity of 10.86% beat Rimini Street's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rimini Street	8.30%	-24.30%	1.64%
OptimizeRx	6.37%	10.86%	7.93%

Rimini Street has higher revenue and earnings than OptimizeRx. Rimini Street is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rimini Street	$421.54M	1.04	$37.10M	$0.37	12.74
OptimizeRx	$109.43M	1.13	$5.13M	$0.35	18.77

Summary

OptimizeRx beats Rimini Street on 9 of the 16 factors compared between the two stocks.

How does OptimizeRx compare to International Money Express?

International Money Express (NASDAQ:IMXI) and OptimizeRx (NASDAQ:OPRX) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

86.7% of International Money Express shares are owned by institutional investors. Comparatively, 76.5% of OptimizeRx shares are owned by institutional investors. 5.1% of International Money Express shares are owned by company insiders. Comparatively, 7.5% of OptimizeRx shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

International Money Express has higher revenue and earnings than OptimizeRx. International Money Express is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
International Money Express	$607.78M	0.69	$32.67M	$0.85	16.31
OptimizeRx	$109.43M	1.13	$5.13M	$0.35	18.77

OptimizeRx has a consensus target price of $13.43, suggesting a potential upside of 104.39%. Given OptimizeRx's stronger consensus rating and higher possible upside, analysts plainly believe OptimizeRx is more favorable than International Money Express.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
International Money Express	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

OptimizeRx has a net margin of 6.37% compared to International Money Express' net margin of 4.34%. International Money Express' return on equity of 23.26% beat OptimizeRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
International Money Express	4.34%	23.26%	6.88%
OptimizeRx	6.37%	10.86%	7.93%

In the previous week, OptimizeRx had 3 more articles in the media than International Money Express. MarketBeat recorded 5 mentions for OptimizeRx and 2 mentions for International Money Express. International Money Express' average media sentiment score of 0.94 beat OptimizeRx's score of 0.58 indicating that International Money Express is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
International Money Express	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OptimizeRx	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

International Money Express has a beta of 0.75, indicating that its stock price is 25% less volatile than the broader market. Comparatively, OptimizeRx has a beta of 1.08, indicating that its stock price is 8% more volatile than the broader market.

Summary

OptimizeRx beats International Money Express on 10 of the 16 factors compared between the two stocks.

Get OptimizeRx News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OPRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OPRX vs. The Competition

Export

Metric	OptimizeRx	COMP Industry	Computer Sector	NASDAQ Exchange
Market Cap	$123.07M	$129.59B	$38.53B	$12.50B
Dividend Yield	N/A	2.06%	3.19%	8.00%
P/E Ratio	18.74	22.39	78.81	24.41
Price / Sales	1.13	4.57	598.74	117.36
Price / Cash	6.51	17.12	45.82	49.36
Price / Book	0.95	35.78	9.55	6.33
Net Income	$5.13M	$5.27B	$1.07B	$330.66M
7 Day Performance	4.45%	-1.26%	0.04%	-0.66%
1 Month Performance	25.62%	1.90%	-0.88%	-0.14%
1 Year Performance	-48.19%	-22.85%	141.88%	20.16%

OptimizeRx Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OPRX OptimizeRx	4.7829 of 5 stars	$6.57 +0.3%	$13.43 +104.4%	-48.4%	$123.07M	$109.43M	18.74	100	Analyst Upgrade Short Interest Decrease
PAYS Paysign	3.1959 of 5 stars	$8.42 +0.8%	$10.00 +18.8%	+16.2%	$470.76M	$82.03M	49.53	80
IBEX IBEX	2.6812 of 5 stars	$33.68 +3.2%	$40.00 +18.8%	+18.4%	$450.92M	$558.27M	10.52	33,000
GRVY GRAVITY	1.5292 of 5 stars	$63.70 -1.6%	N/A	+0.0%	$442.72M	$388.04M	8.73	340
RMNI Rimini Street	3.8924 of 5 stars	$4.72 +1.2%	$5.50 +16.6%	-9.0%	$436.42M	$421.54M	12.74	1,980

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OPRX) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OptimizeRx (OPRX) Competitors